NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) (NCT01730937) Meeting Abstract
| Authors: | Dawson, L. A.; Winter, K.; Knox, J.; Zhu, A. X.; Krishnan, S.; Guha, C.; Kachnic, L. A.; Gillin, M. T.; Hong, T. S.; Craig, T.; Hosni, A.; Chen, E.; Noonan, A.; Koay, E. J.; Sinha, R.; Lock, M. I.; Ohri, N.; Dorth, J. A.; Moughan, J.; Crane, C. H. |
| Abstract Title: | NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) (NCT01730937) |
| Meeting Title: | 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2022) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 114 |
| Issue: | 5 |
| Meeting Dates: | 2022 Oct 23-26 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-12-01 |
| Start Page: | 1057 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2022.09.002 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: LBA 01 -- Meeting was also held virtually -- Source: Cinahl |
